The Orienting Study

Recruiting Observational Study
CPPD - Calcium Pyrophosphate Deposition Disease Gout
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
450 (estimated)
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study at IRCCS Galeazzi - Sant'Ambrogio Hospital involves patients with gout, CPPD, and osteoarthritis as a control group. Patients will receive routine care with regular clinical, laboratory, and imaging assessments every six months, alongside urgent visits as needed. The study aims to understand crystal deposits in joints and blood vessels and monitor their progression over time, assessing …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
The inclusion criteria for CPPD patients are: * Patients diagnosed with CPPD disease according to the ACR/EULAR 2023 classification criteria. * Patients with evidence of asymptomatic CPPD on US or X-rays (not meeting the classification criteria) according to validated imaging definitions. * Aged ol…
Contacts

Georgios Filippou, MD

0039 0283502707

georgios.filippou@grupposandonato.it

CONTACT

Silvia Sirotti, MD

0039 0283502708

silvia.sirotti@grupposandonato.it

CONTACT